NCT00542087View on ClinicalTrials.gov

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

516

Participants

Timeline

Start Date

March 22, 2002

Primary Completion Date

December 20, 2002

Study Completion Date

December 20, 2002

Conditions
Osteoarthritis
Interventions
DRUG

MK0663, etoricoxib / Duration of Treatment: 6 Weeks

DRUG

Comparator: diclofenac sodium / Duration of Treatment: 6 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00542087 - Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED) | Biotech Hunter | Biotech Hunter